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Abstract
Macrophages are one of the most important HIV-1 target cells. Unlike CD4+ T cells, macrophages are resistant to the
cytophatic effect of HIV-1. They are able to produce and harbor the virus for long periods acting as a viral reservoir.
Candida albicans (CA) is a commensal fungus that colonizes the portals of HIV-1 entry, such as the vagina and the
rectum, and becomes an aggressive pathogen in AIDS patients. In this study, we analyzed the ability of CA to
modulate the course of HIV-1 infection in human monocyte-derived macrophages. We found that CA abrogated
HIV-1 replication in macrophages when it was evaluated 7 days after virus inoculation. A similar inhibitory effect was
observed in monocyte-derived dendritic cells. The analysis of the mechanisms responsible for the inhibition of HIV-1
production in macrophages revealed that CA efficiently sequesters HIV-1 particles avoiding its infectivity. Moreover,
by acting on macrophages themselves, CA diminishes their permissibility to HIV-1 infection by reducing the
expression of CD4, enhancing the production of the CCR5-interacting chemokines CCL3/MIP-1α, CCL4/MIP-1β, and
CCL5/RANTES, and stimulating the production of interferon-α and the restriction factors APOBEC3G, APOBEC3F,
and tetherin. Interestingly, abrogation of HIV-1 replication was overcome when the infection of macrophages was
evaluated 2-3 weeks after virus inoculation. However, this reactivation of HIV-1 infection could be silenced by CA
when added periodically to HIV-1-challenged macrophages. The induction of a silent HIV-1 infection in macrophages
at the periphery, where cells are continuously confronted with CA, might help HIV-1 to evade the immune response
and to promote resistance to antiretroviral therapy.
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Introduction
HIV-1 infections are mainly acquired through sexual contact.
After deposition of HIV-1 on the recipient mucosa, the
infectious virus must cross the mucosal epithelium and interact
with resident CD4+ T lymphocytes, macrophages and dendritic
cells (DCs), the three major targets of HIV-1 infection. These
cells express the receptor CD4 and the coreceptors CXCR4 or
CCR5 required for HIV-1 infection [1,2]. Unlike CD4+ T
lymphocytes, macrophages are more resistant to the cytopathic
effects of HIV-1. They are able to produce and accumulate
replication competent virus for long periods even in patients on
highly active antiretroviral therapy (HAART) [3–5]. This feature,
together with their ubiquitous distribution in all tissues,
including the central nervous system, explains why
macrophages play an important role in the spreading of HIV-1
infection [3–5].
Due to the limited accessibility and inefficient recovery of
tissue macrophages, most studies focused on the analysis of
the infection of mononuclear phagocytes by HIV-1 used
macrophages differentiated from blood monocytes. The
kinetics of HIV-1 replication appears to be similar in these
macrophages compared with tissue macrophages [4,6]. The
production of virus particles using R5 tropic virus increases
linearly over time reaching a maximum at 14 days after virus
inoculation. Then, macrophages sustain high levels of viral
production for at least 2 months post-infection [7]. Infected
macrophages are not only able to produce infective viruses.
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Macrophages together with resting (naive and memory) CD4+ T
cells constitute latent HIV-1 reservoirs. These long-lived HIV-1
reservoirs evade the immune response and persist for long
periods, even in the presence of successful HAART. In fact,
they represent a major obstacle for the eradication of HIV-1 in
HAART-treated patients [8,9].
The capacity of infected macrophages to produce HIV-1 can
be modulated in several ways. Activation of TLR3, 4, 7 and 8
arrests HIV-1 infection after virus entry, but before reverse
transcription [10]. In contrast, polybacterial challenge enhances
HIV-1 reactivation in latently infected macrophages and DCs
[11]. Cytokine-induced polarization of macrophages into
classical activated macrophages results in a reduced capacity
to support a productive infection due to the inhibition of an early
preintegration step in the viral life cycle [12]. Polarization into
alternatively activated macrophages also results in HIV-1
production decrease. However, in this case, inhibition occurs at
a late postintegration level in the viral life cycle [12]. On the
other hand, contradictory results have been reported on the
ability of other agents such as M. tuberculosis or LPS to
modulate the rate of HIV-1 production by infected
macrophages [13–17].
Candida albicans (CA) is a polymorphic fungus and a
commensal microorganism in the healthy subject that colonizes
the human gastrointestinal tract, the oral cavity and the vagina.
However, in the immunocompromised host, CA becomes an
aggressive pathogen. In fact, oropharyngeal candidiasis affects
up to 50% of untreated HIV-1+ subjects and 90% of AIDS
patients [18,19]. Interestingly, HIV-1 directly interacts with CA
and this interaction appears to enhance fungal virulence
[20,21]. Moreover, HIV-1 has shown to inhibit phagocytosis of
CA mediated by macrophages [22]. In this study, we analyzed
the ability of CA to modulate the course of HIV-1 infection in
monocyte-derived macrophages. We found that CA abrogates
the early production of HIV-1 by infected macrophages favoring
the establishment of a silent infection.
Materials and Methods
Reagents
Trypsin, zymosan A from Saccharomyces cerevisiae, and
recombinant human granulocyte-macrophage colony-
stimulating factor (GM-CSF) were from Sigma-Aldrich (St.
Louis, MO, USA). Recombinant human interleukin-4 (IL-4) was
from Preprotech (Rocky Hill, NJ, USA) or R&D Systems
(Minneapolis, MN, USA). Ficoll-Hypaque was from Amersham
Pharmacia Biotech (Piscataway, NJ, USA). RPMI 1640
medium supplemented with 10% heat-inactivated fetal calf
serum (FCS), 50 U of penicillin/ml and 50 µg of streptomycin/ml
(Life Technologies, Grand Island, NY, USA) was used as
culture medium. This medium was supplemented with anfostat
(1µg/ml) (Life Technologies) in those experiments performed
with CA.
Preparation of macrophages and dendritic cells
Human peripheral blood mononuclear cells (PBMCs) were
obtained from healthy volunteers after provision of written
informed consent, and in accordance with the principles of the
Declaration of Helsinki, through protocols approved by the
Institutional Board from the National Academy of Medicine
(Buenos Aires, Argentina). All the research was conducted in
Argentina. PBMCs were isolated from blood of healthy donors
by density gradient centrifugation on Ficoll-Hypaque. CD14+
cells were obtained using CD14 microbeads (Miltenyi Biotec,
Auburn, CA, USA). To obtain DCs, monocytes were cultured
for 5 days with 20 ng/ml IL-4 and 10 ng/ml GM-CSF [2,3]. To
obtain macrophages, monocytes were cultured with 20 ng/ml
GM-CSF for 5 days [2,4].
Cell lines and virus
The R5 tropic virus HIV-1BaL [2,5], the X4 tropic virus HIV-1IIIB
[2,5], and the T cell line Jurkat [2,6] were obtained from the
AIDS Research and Reference Reagent Program, Division of
AIDS, National Institute of Allergy and Infectious Diseases,
National Institutes of Health. The HIV-1BaL strain was grown on
monocyte-derived macrophages and the HIV-1IIIB strain was
obtained from H9HTLVIIIB supernatants, as described [2,7].
Viruses were concentrated by ultracentrifugation at 28,000 rpm
for 90 min at 4°C (L2-65B ultracentrifuge; Beckman Coulter,
Brea, CA, USA), and the virus pellet was suspended in RPMI
1640 medium. p24 antigen levels were determined by ELISA
(bioMérieux, Vironostika, Buenos Aires, Argentina), and the
virus input into assays was a function of p24 antigen
concentration.
Flow cytometry
Fluorescein isothiocyanate- phycoerythrin-, or
allophycocyanin- conjugated mAbs directed to CD1a, CD14,
CD4, DC-SIGN, CD86, CD83, HLA-DR, CCR7, and CCR5
were from BD Pharmingen (San Diego, CA, USA). Anti-CD317
(BST-2) was from eBioscience (San Diego, CA, USA). A
fluorescein isothiocyanate (KC57-FITC) conjugated mAb
directed to HIV-1 proteins 55, 39, 33, and 24kD of core antigen
was from Beckman Coulter (Fullerton, CA, USA). The analysis
was performed using a FACS flow cytometer and the CellQuest
software (BD Biosciences, San Jose, CA, USA).
Quantification of cellular apoptosis by annexin-V
binding and flow cytometry
It was performed using an apoptosis detection kit
(Immunotech, Marseille, France). In brief, cells were labeled
with annexin-V-FITC for 20 min at 4°C and with propidium
iodide immediately before evaluation by flow cytometry [2,8].
HIV-1 binding assays
They were performed as previously described [2,7]. Briefly,
CA (1x106 to 1x107) or zymosan (100 µg) suspended in 0.5 ml
of culture medium were incubated with HIV-1 (50 ng p24/ml) for
60 min at 37°C, washed thoroughly, pelleted, lysed, and
assayed for p24 antigen by ELISA.
HIV-1 infection assays
They were performed as previously described [2,7]. Adherent
macrophages, DCs, or Jurkat cells (5x105/0.5ml) were cultured
in 24 flat-bottom plates with the R5 tropic virus HIV-1BaL or the
Candida albicans and Macrophage Infection by HIV
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X4 tropic virus HIV-1IIIB (50 ng p24/ml) for 2 h at 37°C, in the
presence or absence of CA (ATCC10261) or zymosan. Cells
were then washed three times with PBS and cultured for
different periods. Infection was analyzed by measuring the
concentration of p24 antigen in cell supernatants by ELISA or
by studying the expression of intracellular HIV-1 core proteins
by flow cytometry. To neutralize the activity of type I IFNs, a
specific blocking antibody directed to the common receptor
IFN-R was used (clone MMHAR-2, PBL interferon Source, NJ,
USA).
Transmission of HIV-1 from macrophages to activated
mononuclear cells
PBMCs were activated by IL-2 (10 U/ml; R&D Systems) and
PHA (10µg/ml) for 2 days. Macrophages (5x105/0.5 ml) were
cultured in 24 flat-bottom plats with the R5 tropic virus HIV-1BaL
(50 ng p24/ml) for 2 h at 37°C, in the absence or presence of
CA (macrophage: CA ratio of 1:10). Macrophages were then
washed thoroughly and cultured in medium supplemented with
10 ng/ml of GM-CSF. Transmission assays were performed as
previously described [2,7] by incubating 5x105 HIV-1-treated
macrophages with 2.5x105 activated PBMCs in a final volume
of 0.5 ml in 24 flat-bottom plats. Supernatants harvested at 4
and 8 days of culture were assayed for p24 antigen by ELISA.
Confocal microscopy
Macrophages (5x105 cells/0.5ml) were cultured with or
without FITC labeled-CA for 18 h (macrophage: CA ratio of
1:10). Macrophages were then harvested and plated on poly-L-
lysine-coated glass coverslips (12 mm) during 20 min at RT.
Then, cells were washed and fixed in 4% paraformaldehyde
(10 min on ice) and washed twice with 0.1 mM glycine in PBS.
Subsequently, cells were incubated with a mouse mAb directed
to CD4 for 1 h, and revealed with DyLight549-conjugated anti-
mouse mAb for 45 min. Coverslips were mounted on glass
slides using Fluoromount G. Immunofluorescence and images
were acquired with a FluoView FV1000 confocal microscope
(Olympus, Tokyo, Japan) using a Plapon 60-1.42 NA oil
immersion objective. Images were analyzed using the Olympus
FV10-ASW software.
HIV-1 DNA detection
Total macrophage DNA was isolated 18 h post-infection
using the DNeasy Blood and Tissue Kit (QIAGEN, Alameda,
CA) according to the manufacturer’s instructions. Two different
HIV-1 genomic regions were targeted for PCR amplification:
the gag region (132 bp) and the env region (322 bp). Nested
PCR was then performed with Taq DNA polymerase and
buffers (Invitrogen, Carlsbad, CA, USA), under the conditions
recommended by the manufacturer. Primers used for first-
round amplification were (Gag 1 5’-GAA GGC TTT CAG CCC
AGA AG-3’; Gag 2 5’-TCT CCT ACT GGG ATA GGT GG-3’;
Env 1 5’-CAC AGT ACA ATG TAC ACA TG-3’; Env 2 5’-ACA
GTA GAA AAA TTC CCC TC-3’). β-Actin was amplified as a
control (Act 1 5’-GGA CCT GAC TGA CTA CCT CAT GAA-3’;
Act 2 5’-GAT CCA CAT CTG CTG GAA GGT GGG AG-3’).
The following amplification conditions were used: 5 min at
95°C, followed by 25 cycles of 30s at 95°C, 30s at 60°C, 30s at
75°C, and a final extension step at 72°C for 5 min. Primers
used for second-round amplification were (Gag 3 5’-ACC ATC
AAT GAG GAA GCT GC-3’; Gag 4 5’-TAT TTG TTC CTG AAG
GGT AC-3’; Env 3 5’-AAA TGG CAG TCT AGC AGA AG-3’;
Env 4 5’-ACA ATT TCT GGG TCC CCT CC-3’), following the
same conditions to those used in the first round.
RNA extraction, cDNA synthesis and quantitative Real-
Time PCR
Total RNA was extracted from 2x106 macrophages using
TRIzol® Invitrogen, according to the manufacturer’s
instructions. It was transcribed to cDNA using random primers
and M-MLV RT (Invitrogen). Specific primer pairs for each
gene (Invitrogen) were designed: CCL3 (GI: 121582465) (fw
5’-AGTTCTCTGCATCACTTGCTG-3’, rev 5’-
CGGCTTCGCTTGGTTAGGAA-3’); CCL4 (GI: 59799728) (fw
5’-CTGTGCTGATCCCAGTGAATC-3', rev 5’-
TCAGTTCAGTTCCAGGTCATACA-3’); CCL5 (GI: 22538813)
(fw 5’-ATCCTCATTGCTACTGCCCTC-3’, rev 5’-
GCCACTGGTGTAGAAATACTCC-3’); APOBEC3F (GI:
109451045) (fw 5’-TACGCAAAGCCTATGGTCGG-3’, rev 5’-
GCTCCAAGATGTGTACCAGC-3’); APOBEC3G (GI:
109451183) (fw 5’-GCTGTGCTTCCTGGACGTGA-3’, rev 5’-
GGTGGTCCACAAAGGTGTCCC-3’); GAPDH (GI: 354515022)
(fw 5’-GAGTCAACGGATTTGGTCGT-3’, rev 5’-
TTGATTTTGGAGGGATCTCG-3’). Gene expression analysis
was performed on a 7500 Real Time PCR System (Applied
Biosystems, Foster, CA, USA) using SYBR®Green PCR
Master Mix for detection of PCR product (Applied Biosystems).
All reactions were performed in duplicate with appropriate non-
template controls. Finally, a melting curve analysis was
performed to verify the specificity of the amplicon.
Statistical analysis
All statistical comparisons were performed using one-way
analysis of variance with Dunnett post-test. P values <0.05
were considered statistically significant.
Results
Candida albicans inhibits the replication of HIV-1 in
macrophages and dendritic cells
In a first set of experiments we analyzed the kinetics of HIV-1
infection in monocyte-derived macrophages. Macrophages
were cultured with the R5 tropic virus HIV-1BaL for 2 h. Then,
cells were washed and the infection of macrophages was
evaluated at days 0, 3, 5 and 7 by measuring the amount of
p24 antigen in cell supernatants by ELISA. Significant amounts
of p24 antigen were detected after 5 days of infection (Figure
1A). We then analyzed whether CA was able to modulate the
infection of macrophages by HIV-1. Macrophages were
cultured with HIV-1BaL in the absence or presence of CA at a
macrophage: CA ratio of 1:10. After 2 h of culture, cells were
washed and HIV-1 infection was evaluated after 7 days of
culture. Figure 1B shows that CA abrogated the production of
HIV-1 by macrophages. A similar inhibitory effect was observed
using zymosan, a product prepared from the cell wall of the
Candida albicans and Macrophage Infection by HIV
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fungus Saccharomyces cerevisiae. To rule out the possibility
that the decreased production of HIV-1 could be related to a
deleterious effect induced by CA, cellular viability was
evaluated by annexin-V binding and flow cytometry. Figure 1C
shows that neither CA nor zymosan diminished macrophage
viability.
We then analyzed whether CA was also able to inhibit HIV-1
replication in monocyte-derived dendritic cells (DCs). The
phenotype of DCs is illustrated in Figure 1D. As expected, DCs
were CD1a+, CD14-, DC-SIGN+, and showed predominantly an
immature phenotype illustrated by the low expression of CD86
and the absence of CCR7. However, a fraction of DCs (5-20%)
were positive for the expression of CD83 indicating the
presence of a population of mature DCs. The kinetics of HIV-1
infection revealed that significant amounts of p24 were
detected in cell supernatants after 5 days of infection (Figure
1E). Similarly to macrophages, the production of HIV-1 by DCs
was markedly reduced by either CA or zymosan (Figure 1F). In
contrast with the findings observed in macrophages and DCs,
CA did not exert any inhibitory effect on the infection of the
Jurkat T cell line by the X4 tropic virus HIV-1IIIB (Figure 1G).
We then evaluated whether CA also impaired the
transmission of the virus from macrophages to activated
peripheral blood mononuclear cells (PBMCs). In these
experiments macrophages were cultured for 2 h with the R5
tropic virus HIV-1BaL in the absence or presence of CA
(macrophage: CA ratio of 1:10). Cells were then washed and
cultured with activated PBMCs using a macrophage: PBMC
ratio of 2:1. The production of HIV-1 was evaluated at days 4
and 8 post-infection. Results in Figure 2 show that CA
markedly inhibited the production of HIV-1 in cocultures of
macrophages and activated PBMCs.
Analysis of the mechanisms through which Candida
albicans inhibit HIV-1 replication in macrophages
We speculated that the inhibition of HIV-1 infection induced
by CA might involve the sequestering of HIV-1 particles by CA.
Supporting this possibility, previous studies have shown that
CA binds HIV-1 through a mechanism depending on the
interaction between the C3-like regions of the HIV-1
transmembrane protein gp41 and C3 binding moieties on CA
[20,21]. Consistent with these observations, we found that both
CA and zymosan efficiently bind HIV-1 (Figure 3A). In fact,
5x106 CA bind a similar amount of HIV-1 than 1x106 PBMCs
(Figure 3A). The attached virus remained at the yeast surface
(it was removed by trypsin) (Figure 3B) and was completely
unable to start a productive infection in macrophages (Figure
3C). To further analyze whether the sequestering of HIV-1 by
CA could account for the inhibition of HIV-1 infection, a new set
of experiments was performed under conditions directed to
minimize the interaction between CA and HIV-1. To this aim,
macrophages were incubated with HIV-1 for 2 h. Cells were
washed and CA was then added using a macrophage: CA ratio
of 1:10. Infection of macrophages was revealed at day 7 post-
infection. Results in Figure 3D show that, even under these
experimental conditions, CA inhibited the production of HIV-1.
However, the inhibitory effect was significantly lower compared
with the inhibition of HIV-1 production observed when
macrophages were cultured together with both CA and HIV-1
(Figure 3D). This suggests that sequestering of HIV-1 particles
by CA might contribute to the inhibition of HIV-1 infection. Also
supporting this view, we found that when HIV-1 stocks were
pre-incubated with CA and the infectivity of these stocks in
macrophages were measured after depletion of CA by
centrifugation, a significant inhibition was observed (data not
shown).
We then analyzed whether the ability of CA to suppress
HIV-1 replication could also be related to changes in the
phenotype of macrophages. We first looked at the expression
of CD4 and CCR5. Macrophages were incubated with CA for 2
h at different macrophage: CA ratios, washed and cultured for
18 h. Then, the expression of CD4 and CCR5 was analyzed by
flow cytometry or confocal microscopy. Figure 4A shows that
CA markedly inhibited the expression of CD4 while slightly
increased the expression of CCR5. Considering that the CC
chemokines CCL3/MIP-1α, CCL4/MIP-1β, and CCL5/RANTES
block the entry of R5 tropic virus into host cells [2,9], we also
analyzed the levels of mRNA for these chemokines. Figure 4B
shows that activation of macrophages by CA stimulated the
production of CCL3, CCL4, and CCL5, as revealed by
quantitative PCR.
The inhibition of HIV-1 replication in macrophages induced
by CA could also be related to an increased expression of host
restriction factors able to block retroviral replication.
APOBEC3G and APOBEC3F are cytidine deaminases that
introduce G to A substitutions in the HIV-1 genome inhibiting
viral replication [30]. On the other hand, tetherin (Bst-2) impairs
the release of virions by “tethering” mature virions to the cell
membrane [31]. We then analyzed whether CA was able to
stimulate the expression of these retroviral restriction factors in
macrophages. In these experiments, cells were incubated for 2
Figure 2.  Candida albicans inhibits transmission of HIV-1
from macrophages to activated peripheral blood
mononuclear cells.  Macrophages (5x105/0.5 ml) were
incubated with the R5 tropic virus HIV-1BaL (50 ng p24/ml) for 2
h in the absence or presence of CA (macrophages: CA ratio of
1:10). Cells were then washed and cultured with activated
PBMCs (2.5 x105). Infection was revealed after 4 and 8 days of
culture by measuring the amount of p24 antigen in cell
supernatants by ELISA. Results are expressed as the
arithmetic means ± SEM of 4 experiments. * p<0.05 vs HIV +
PBMC.
doi: 10.1371/journal.pone.0072814.g002
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Figure 1.  Candida albicans abrogates the production of virus particles by HIV-1-challenged macrophages.  (A)
Macrophages (5x105/0.5 ml) were cultured in 24 flat-bottom plats with the R5 tropic virus HIV-1BaL (50 ng p24/ml) for 2 h. Then, cells
were washed and the production of HIV-1 was evaluated at days 0, 3, 5 and 7 post-infection by measuring the amount of p24
antigen in cell supernatants (n=4). (B) Macrophages were cultured with HIV-1BaL (50 ng p24/ml) for 2 h in the absence or presence
of CA (macrophage: CA ratio of 1:10) or zymosan (100 µg/0.5 ml). Then, cells were washed and the production of HIV-1 was
evaluated after 7 days (n=9). (C) Macrophages were cultured for 7 days in the absence or presence of HIV-1BaL (50 ng p24/ml), CA
(macrophage: CA ratio of 1:10) or zymosan (100 µg/0.5 ml). Then, the viability of macrophages was analyzed by flow cytometry
using Annexin V and propidium iodide. Positive control of necrosis represents macrophages cultured for 3 days in protein-free
medium (n=3). (D) Histograms illustrate the phenotype of DCs used in our experiments (n=5). (E) DCs (5x105/0.5 ml) were cultured
with HIV-1BaL (50 ng p24/ml) for 2 h. Then, cells were washed and the production of HIV-1 was evaluated at days 0, 3, 5 and 7 post-
infection (n=4). (F) DCs were cultured with HIV-1BaL (50 ng p24/ml) for 2 h in the absence or presence of CA (macrophage: CA ratio
of 1:10) or zymosan (100 µg/0.5 ml). Then, cells were washed and the production of HIV-1 was evaluated after 7 days of culture
(n=5). (G) The T cell line Jurkat (5x105/0.5 ml) was incubated with the X4 tropic virus HIV-1IIIB (50 ng p24/ml) and CA (Jurkat: CA
ratios of 1:10, 1:1, and 1:0.1) for 2 h. Cells were then washed and HIV infection was revealed after 7 days (n=3). In all cases, results
are expressed as the arithmetic means ± SEM of n experiments or are illustrated as representative dot-plot or histograms. *p<0.05
vs HIV.
doi: 10.1371/journal.pone.0072814.g001
Candida albicans and Macrophage Infection by HIV
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h at a macrophage: CA ratio of 1:10, washed and cultured for
18 h. Then, the presence of mRNA for APOBEC3F and
APOBEC3G was evaluated by quantitative PCR while the
expression of tetherin was analyzed by flow cytometry. Figure
5A shows that CA stimulated the expression of APOBEC3F,
APOBEC3G and tetherin. Considering that type I IFNs
represent the most potent inducer of these restriction factors,
we looked at the production of interferon-α. Figure 5B shows
that CA effectively stimulated the production of interferon-α by
macrophages. Interestingly, the addition of saturating
concentrations of a blocking monoclonal antibody directed to
the receptor for type I IFNs partially prevented the inhibition of
HIV-1 infection in macrophages induced by CA (Figure 5C),
suggesting the participation of type I IFNs in the anti-viral effect
induced by CA.
Candida albicans promotes and sustains a latent-like
HIV-1 infection in macrophages
Results in Figure 6A show that HIV-1 DNA was similarly
detected in macrophages challenged by HIV-1 either in the
absence or presence of CA, suggesting that the inhibitory
effect of CA on HIV-1 replication is related to the inhibition of a
post-entry step of the viral life cycle. We then asked whether
macrophages would be able to overcome this form of latency.
To answer this question, we next performed kinetic studies in
which the production of viral particles was analyzed at days 7,
12 and 18 post-exposure to HIV-1. In these experiments,
macrophages were cultured with HIV-1Bal in the absence or
presence of CA (macrophage: CA ratios of 1:10 and 1:1). Cells
were washed and infection was revealed at days 7, 12, and 18.
The results obtained are shown in Figure 6B and C. Candida
albicans markedly inhibited the production of HIV-1 when
evaluated at either 7 or 12 days post-exposure. However, this
inhibitory effect was largely overcome when infection was
evaluated 18 days post-infection. Interestingly, as shown in
Figure 6D, the delayed reactivation of HIV-1 infection could be
silenced by longer periods when CA was added periodically to
HIV-1-challenged macrophages.
Discussion
Whereas HIV-1 can infect a variety of cell types, CD4+ T
cells, macrophages and DCs represent the three main targets
of HIV-1 infection [1,2]. Although the virus follows a similar life
cycle in CD4+ T lymphocytes and macrophages, the infection of
both cell types shows major differences. One of the most
striking differences consists in the high resistance of
macrophages to the cytopathic effects of HIV-1. CD4+ T cells
rapidly die by apoptosis upon acute infection showing a half-life
of a few days [32,33]. In contrast, infected macrophages
survive for months after acute infection, and as a result they
can accumulate and produce high levels of virus for long
periods of time [3–5].
The introduction of the HAART in 1996 unveiled the
presence of latent and long-lived viral reservoirs which
constitute a major obstacle for HIV-1 eradication. Both, CD4+
Figure 3.  Candida albicans sequesters HIV-1 particles.  (A) CA (1x106-1x107/0.5 ml), zymosan (100 µg/0.5 ml), or activated
PBMCs (1x106/0.5 ml) were incubated with HIV-1BaL (50 ng p24/ml) for 2 h, washed thoroughly, lysed, and assayed for p24 antigen
by ELISA. A representative experiment (n=4) is shown. (B) CA (1x106/0.5 ml) was incubated with HIV-1BaL (50 ng p24/ml) for 2 h,
washed thoroughly, treated with trypsin (1000 U/ml, 15 min at 37°), lysed and assayed for p24 antigen. Bars represent the
arithmetic means ± SEM of four experiments. * p<0.05 vs C. albicans. (C) CA (5x106/0.5 ml) was incubated with HIV-1BaL (50 ng
p24/ml) for 2 h and washed thoroughly. Macrophages (5x105/0.5 ml) were cultured for 7 days with HIV-treated CA and the levels of
p24 antigen in cell supernatants was assayed by ELISA. Bars represent the arithmetic means ± SEM of four experiments. * p<0.05
vs macrophages infected by HIV-1. (D) Macrophages (5x105/0.5 ml) were incubated with HIV-1BaL (50 ng p24/ml) for 2 h in the
presence (HIV + CA) or absence (HIV + CA after) of CA, and washed three times with PBS. Cells were then cultured for an
additional period of 2 h in the absence (HIV + CA) or presence (HIV + CA after) of CA. Cells were washed again and HIV-1 infection
was evaluated after 7 days. The macrophage: CA ratio used in these experiments was 1:10. Bars represent the arithmetic means ±
SEM of 6 experiments. * p<0.05 vs HIV + CA.
doi: 10.1371/journal.pone.0072814.g003
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PLOS ONE | www.plosone.org 6 August 2013 | Volume 8 | Issue 8 | e72814
 resting T cells (naive and memory) and macrophages seem to
be the most important reservoirs for HIV-1, and the presence of
latent proviral DNA has been clearly demonstrated in these
cellular populations [8,9,3,4]. A large number of studies have
been performed to analyze the mechanisms responsible for the
induction and maintenance of HIV-1 latency in CD4+ T cells,
while less attention has been paid to the analysis of latency in
macrophages. However, for both cell types two forms of
latency have been described: pre-integration latency and post-
integration latency [5,8,9].
A variety of stimuli have shown to modulate in vitro the
course of HIV-1 infection in macrophages. IFN-α potently
inhibits HIV-1 replication in macrophages while IL-1β and IL-6
stimulate virus replication [35,3,6]. IL-4 and IL-13 enhance
virus replication in monocytes but suppress HIV-1 replication in
macrophages [3,7]. Polarization of macrophages into a M1
profile induced by TNF-α plus IFN-γ leads to a decreased
capacity to support HIV-1 replication [12,38]. Contradictory
results have been published in regard to the ability of M.
tuberculosis to modulate the course of HIV-1 infection in
macrophages [13,14], while M. avium and M. xenopi have
shown to enhance HIV-1 replication [39,40]. Gram-negative
polybacterial challenge enhances HIV-1 replication in
macrophage and DCs [11] while phagocytosis of apoptotic cells
stimulates HIV-1 replication in mononuclear phagocytes [41].
In this study we show that the fungus CA almost completely
abrogates the early production of viral particles by
macrophages and DCs challenged by HIV-1. Not only the
production of HIV-1 but also the ability of macrophages to
transmit the virus to activated mononuclear cells were
abolished by CA. Our results suggest that CA suppresses
HIV-1 production in macrophages by a number of mechanisms.
First, it efficiently attaches HIV-1 particles. In contrast with
previous observations made in other non-permissive cells such
Figure 4.  Candida albicans down-regulates CD4 expression and stimulates the production of the CCR5-ligand chemokines
CCL3, CCL4, and CCL5 in macrophages.  Macrophages (5x105/0.5 ml) were cultured for 2 h in the absence or presence of CA
using a macrophage: CA ratio of 1:10, unless otherwise stated. Cells were then washed and cultured for an additional period of 18
h. Then, the expression of CD4 and CCR5 was analyzed by flow cytometry or confocal miscroscopy (A) and the production of the
chemokines CCL3, CCL4 and CCL5 was evaluated in cell supernatants by quantitative PCR (relativized to the expression of
GAPDH mRNA) (B). In (A), graph bars show the relative mean fluorescence intensity (MFI) of CD4 or CCR5. The MFI of untreated
macrophages is assigned the value of 100. Results are expressed as the arithmetic means ± SEM of 4-5 experiments. Confocal
images of a representative experiment (n=4) are also shown. Bars represent 10 µm. In (B), representative experiments are shown
(n=4).
doi: 10.1371/journal.pone.0072814.g004
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as epithelial cells [42], spermatozoa [27] and erythrocytes [43]
indicating that attached virions are efficiently transmitted to
macrophages and DCs, promoting the spreading of HIV-1
infection, we found that CA-attached HIV-1 was completely
unable to start a productive infection in macrophages, perhaps
reflecting the ability of CA to drive the virus into a degradation
pathway inside macrophages. Moreover, we speculate that CA
might also inhibit the infection of macrophages and DCs not
only by sequestering HIV-1 particles but also by competing with
HIV-1 for binding sites on the cell surface, a possibility that
should be tested experimentally. Secondly, CA markedly
reduced the expression of CD4 while enhanced the production
of the CCR5 chemokine ligands CCL3/MIP-1α, CCL4/MIP-1β,
and CCL5/RANTES. Thirdly, CA stimulated the production of
interferon-α and the restriction factors APOBEC3G,
APOBEC3F, and tetherin. Moreover, supporting a role for type
I IFNs we found that blocking of the receptor for type I IFNs
partially, but significantly prevented the inhibitory effect of CA
on the production of HIV-1 by infected macrophages.
Two previous reports analyzed the effect of CA on HIV-1
infection in DCs [44,4,5]. Both studies showed that CA partially
restricts HIV-1 amplification in DCs while increases DC to T-
cell transmission of HIV-1. Contrasting with these observations,
our results in macrophages showed that CA abrogates not only
the replication of HIV-1 in macrophages but also their ability to
transmit the virus to activated PBMCs. This suggests that CA
exerts opposite effects on the ability of macrophages and DCs
to transmit HIV-1 infection to CD4+ T cells.
We also found that the inhibitory effect induced by CA on the
production of HIV-1 by macrophages was overcome when
infection was evaluated 18 days after virus inoculation.
Interestingly, this delayed reactivation of HIV-1 infection in
macrophages could be silenced by longer periods when CA
was added periodically to cell cultures thus suggesting that CA
Figure 5.  Candida albicans stimulates the production of the retroviral host-restriction factors APOBEC3G, APOBEC3F,
tetherin, and interferon-α.  (A and B) Macrophages (5x105/0.5 ml) were cultured for 2 h in the absence or presence of CA using a
macrophage: CA ratio of 1:10. Cells were then washed and cultured for an additional period of 18 h. Then, the presence of
APOBEC3F and APOBEC3G was evaluated by quantitative PCR (relativized to the expression of GAPDH mRNA), the expression
of tetherin (Bst-2) analyzed by flow cytometry, and the amount of IFN-α quantified in cell supernatants by ELISA. (C) Macrophages
(5x105/0.5 ml) were cultured with HIV-1BaL (50 ng p24/ml) in the absence or presence of CA (macrophage: CA ratio of 1:10). Then,
cells were washed and incubated with or without saturating concentrations of a blocking monoclonal antibody directed to the
receptor for type I IFNs. The production of HIV-1 was evaluated at day 7 post-infection. In (A), representative experiments are
shown (4,5). Bars represent the arithmetic means ± SEM of 5 experiments. (A and B) *p<0.05 vs M. (C) *p<0.05 vs M or M+CA
+anti-IFNR.
doi: 10.1371/journal.pone.0072814.g005
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might promote and sustain a latent-like HIV-1 infection in
macrophages.
Candida albicans normally colonizes the portals of HIV-1
entry, such as the vagina and the rectum. Moreover,
mucocutaneous candidiasis is one of the most common
manifestations of HIV-1 infection [18,19]. Since CA can infect,
survive and persist in macrophages [46–44,8], it is reasonable
to speculate that coinfection of macrophages by HIV-1 and CA
might occur in infected patients in the periphery, at the portals
of HIV-1 entry. In this scenario, suppression of HIV-1
replication in macrophages induced by CA could induce
opposite effects on the course of HIV-1 infection. It might
prevent the spreading of HIV-1 by macrophages. However, the
induction of a silent infection in the macrophage might help
HIV-1 to evade the immune response and to promote
resistance to antiretroviral therapy. Further studies are needed
to establish whether coinfection of macrophages by both HIV-1
and CA occurs in coinfected patients as well as the influence of
CA on HIV-1 infection of macrophages in vivo.
Figure 6.  Candida albicans promotes and sustains a latent-like HIV-1 infection in macrophages.  (A) Macrophages
(5x105/0.5 ml) were cultured with HIV-1BaL (50 ng p24/ml) for 2 h at different macrophage: CA ratios. Then, cells were washed
thoroughly and cultured for an additional period of 18 h. PCR amplification of HIV-1 DNA (env, and gag) was performed in cell
lysates and β-actin was evaluated as a control. A representative experiment (n=3) is shown. (B and C) Macrophages (5x105/0.5 ml)
were cultured for 2 h with HIV-1BaL (50 ng p24/ml) in the absence or presence of CA (macrophage: CA ratios of 1:10 and 1:1). Then,
cells were washed and the production of HIV-1 was evaluated at 7, 12, and 18 days post-infection in cell supernatants by p24
ELISA (B) or by intracellular staining of p24 antigen and flow cytometry (C). (B) Graph bars represent the arithmetic means ± SEM
of 4 experiments carried out in duplicate. * p<0.05 vs Mϕ. (C) Dot plots from a representative experiment (n=3) are shown. (D)
Macrophages (5x105/0.5 ml) were cultured with HIV-1BaL (50 ng p24/ml) for 2 h in the absence or presence of CA (macrophage: CA
ratio of 1:10). Then, cells were washed thoroughly and incubated in culture medium. At days 1, 4, or 9 after the initial challenge by
HIV-1, cell cultures were supplemented with additional amounts of CA (macrophage: CA ratio of 1:1), and the production of HIV-1
was evaluated in all cases at day 18 post-infection in cell supernatants by ELISA. Graph bars represent the arithmetic means ±
SEM of 5 experiments. * p<0.05 vs Mϕ cultured without CA (white bar) and ** p<0.05 vs Mϕ + CA (day 0).
doi: 10.1371/journal.pone.0072814.g006
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